Furthermore, despite the molecular mechanism is not fully understood, it has been shown that tumor-derived EVs are able to increase the expansion of CD4+CD25+FoxP3+ Treg cells, inducing their suppressor activity and at the same time blocking the proliferation of activated CD8+ T cells (141, 146). Here, CD8A is linked to neoplasm.